BOT 1.59% 31.0¢ botanix pharmaceuticals ltd

Ann: FDA Confirms Approach to Sofdra NDA Resubmission, page-65

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,370 Posts.
    lightbulb Created with Sketch. 587
    FDA doesn’t mention the human factors at all!!
    just the packaging, which is seen to be acceptable after BOT has updated it. It said nothing more is required aside from the packaging!!
    so it is 5b - draft labeling (now fixed)
    with maybe 5i - a minor clarification info such as, can
    people read instructions rolleyes.png

    So if this is purely Class 1, it’ll explain the rush to get the reading part hurried over Xmas!! It’ll be submitted in January and approved by March.
    Plus also it’s 6 months from the last rejection which was September so it’s March!!!
    The mid 2024 is what I’d say to cover all bets.
    Last edited by FAnotTA: 06/12/23
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
-0.005(1.59%)
Mkt cap ! $563.4M
Open High Low Value Volume
31.5¢ 33.0¢ 31.0¢ $1.731M 5.443M

Buyers (Bids)

No. Vol. Price($)
22 606129 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.5¢ 92444 5
View Market Depth
Last trade - 16.10pm 19/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.